Antibiotic treatment for tough Pseudomonas infections
Part of Infections clinical trials.
This study tests a specific antibiotic plan for adults with a hard-to-treat Pseudomonas infection that needs IV medicine. It aims to find the best way to treat these serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have an infection caused by a hard-to-treat type of Pseudomonas bacteria that needs IV antibiotics.
- You cannot have cystic fibrosis.
- You must not be under a legal guardianship or court protection.
- You must not be in prison or detained.
- You must agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares using one antibiotic alone versus a combination of two antibiotics to treat bone infections caused by Pseudomonas aeruginosa. The goal is to see which approach works better for treating the infection.
This study looks at people’s blood to see if they already have antibodies that recognize Pseudomonas aeruginosa, a type of bacteria. If you qualify for the prospective part, they may collect blood samples at Grenoble University Hospital and use your results to support future treatment testing.
This study looks at the bacteria in the gut of people who are very ill in the hospital. It may help doctors understand how gut health affects recovery.
This trial tests two different antibiotic treatments for adults with bronchiectasis who have a new or recent infection with Pseudomonas aeruginosa (PA) bacteria in their airways. The goal is to see which regimen works better to clear the infection early.
This trial tests whether breathing in special viruses (called phages) that attack the Pseudomonas bacteria can help clear a serious lung infection in patients on ventilators. The treatment is added to standard antibiotics and may help fight the infection better.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
Hear when a new Pseudomonas Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.